Translating the Science of Allergy and Immunology into Clinical Medicine

In this presentation, Dr. David P. Huston, Professor in the Departments of Medicine and Microbial Pathogenesis and Immunology and Associate Dean of the College of Medicine at Texas A&M Health Science Center, updates the audience on recent advances in the fields of allergy and immunology. He  decribes recent insights into disease processes for the type 2 immune response disorders included in the Atopic March: allergic eczema, allergic rhinitis with or without nasal polyps, and allergic asthma. He also reviews recent FDA-approved biologics for the treatment of these conditions.

Dr. Huston discusses the clinical case of a 3-year old girl who presents with pulmonary alveolar proteinosis with a genetic abnormality, and explains how his team identified the etiology of this disease.

Target Audience

This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Discuss recent advances in understanding the molecular mechanism of allergic inflammatory disorders.

  • Apply mechanistic insights on allergic inflammation into strategies for developing therapres for allergic inflammatory disorders.

  • Translate potential therapeutic strategies for allergic inflammatory disorders into a precision clinical medicine approach for managing patients

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/01/2019
Course expires: 
08/31/2021
Rating: 
0

Richard J. Hamill, M.D., Planning Committee Member 
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Erica Lescinskas, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Zaven Sargsyan, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Chirayu Shah, M.D., M.Ed., Planning Committee Member
Associate Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Stephanie Sherman, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Jefferson Triozzi, M.D., Planning Committee Member
Internal Medicine Resident
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.